We are a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Our products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Our comprehensive line of products encircles life itself – addressing important health needs from infancy to the golden years.
As a pharmaceutical company, we know that we’re responsible for more than making medicine. That’s why we are dedicated to providing the tools, resources, support and information needed for a more positive healthcare experience.
AIDS is a continuously growing pandemic, with 40 million people infected with the human immunodeficiency virus (HIV). It is no longer a disease predominantly affecting men. Since 1985, the percentage of women among adults living with HIV has grown particularly, from 35 % to 48 % globally. Worldwide, there are now nearly 18 million women living with the disease. As women may respond to HIV/AIDS treatment differently than men, there is a need for additional medical investigation.
Bristol-Myers Squibb Company
To discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We commit to scientific excellence and investment in biopharmaceutical research and development to provide innovative, high-quality medicines that address the unmet medical needs of patients with serious diseases. We apply scientific rigor to produce clinical and economic benefit through medicines that improve patients’ lives. We strive to make information about our commercialized medicines widely and readily available.
Gilead Sciences, Inc.
Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 14 marketed products, a growing pipeline of investigational drugs and approximately 4,600 employees in offices across four continents. Gilead’s therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation.
We have a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines and products that help millions of people around the world.
Merck & Co.
Our core business is the discovery and development of prescription medicines for diseases and conditions that impact millions of people. We invest billions of research dollars to find medicines that can help improve lives. Today, Merck has more than 50 prescription products in key therapeutic areas, such as cardiovascular disease, respiratory disease, oncology, neuroscience, infectious disease, immunology and women’s health.
Roche Laboratories Inc
At Roche we focus on developing medicines and diagnostics that will help patients live longer, better lives. We strive to address unmet medical needs through excellence in science – from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
We are ViiV Healthcare – a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV. Our aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and then take a new approach to deliver effective and new HIV medicines as well as support communities affected by HIV.